The Breast Cancer Research Foundation (BCRF) is excited to collaborate with streamers of all sizes to raise funds for breast cancer research.
BCRF investigators have been a part of every major breakthrough in breast cancer prevention, diagnosis, treatment, survivorship, and metastasis. We’re dedicated to ending breast cancer by advancing the world’s most promising research, and your fundraising helps us achieve this goal.
Set up a Tiltify account to seamlessly start fundraising, set goals, and create incentives for your community.
Set up a Streamlabs Charity account to use a variety of fundraising tools and custom-made BCRF overlays.
Download our toolkit to access BCRF’s logos, livestream and VOD assets, and more to help you get started.
$50 funds one hour of research.
$100 funds five liquid biopsy collection kits for a clinical trial.
$500 funds one patient’s DNA sequencing in a BCRF-supported lab.
$2,500 funds one patient’s enrollment in a BCRF-supported clinical trial.
BCRF supports more than 260 grantees worldwide with $70.3 million in scientific grants this year.
This year, BCRF is the largest private funder of breast cancer research—and metastatic breast cancer research—globally.
Breast cancer is the most common cancer in women worldwide.
One in eight women in the U.S. will develop invasive breast cancer during their lifetime.
In 2024, an estimated 200,000 women are living with metastatic breast cancer, which can be treated but not cured.
See how other streamers have activated and fundraised for BCRF
To celebrate International Women’s Day and Women’s History Month, Discord hosted a number of events and fundraisers to support BCRF.
Esports team EQNX’s campaign for BCRF—called KO Cancer—raised $11,517 for lifesaving research.
Team Kitty streamers shared BCRF’s mission with new audiences around the world—and raised more than $10,000 for BCRF.
For more information about gaming partnerships, contact us at gaming@bcrf.org.
Please remember BCRF in your will planning. Learn More
2X MATCH
Today, your gift is DOUBLED for 2X the impact on lifesaving research.
